More on Mako (MAKO): Q1 loss widens on higher costs and slower than anticipated sales of its Rio...

|About: MAKO Surgical Corp. (MAKO)|By:, SA News Editor

More on Mako (MAKO): Q1 loss widens on higher costs and slower than anticipated sales of its Rio robotic arm systems. The company now expects to sell between 52 - 58 of the Rio systems for the year, down from its earlier guidance of 56 - 62. Shares -29% AH.